A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection
Citation
K. Kurokohchi et al., A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection, J HEPATOL, 34(6), 2001, pp. 930-935
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
JOURNAL OF HEPATOLOGY
SICI code
0168-8278(200106)34:6<930:ANCTEP>2.0.ZU;2-K
Abstract
Background/Aims: It has been suggested that cytotoxic T lymphocytes (CTL) h
ave crucial roles for the hepatocellular damage in hepatitis C virus (HCV)
infection. A series of CTL epitopes located in the HCV protein have been id
entified. However, no CTL epitopes restricted by HLA-A24, a common HLA alle
le in humans, has been identified.
Methods: Peripheral blood and liver infiltrating mononuclear cells from the
patients with hepatitis C virus infection and healthy controls were stimul
ated with a series of peptides containing HLA-A24 binding motifs located in
HCV protein.
Results: An immunodominant HLA-A24 restricted CTL epitope (A24-4; AYSQQTRGL
, amino acids 1031-1039) presented by HLA-A24 molecule was identified using
a series of synthetic peptides containing the HLA-A24 binding motifs, The
CTL activity against this peptide was induced both in peripheral blood and
liver infiltrating mononuclear cells from HLA-A24-positive chronic hepatiti
s C patients, not from HLA-A24-negative patients and HLA-A24-positive healt
hy controls, CTL activity was blocked by anti-HLA-A24 and anti-CD8 antibodi
es, not by anti-CD4 antibody. Furthermore, the A24-4-specific CTL recognize
d the HCV gene transfected target cells.
Conclusions: Because this peptide is presented by a common HLA class I mole
cule, it might be useful for protection against hepatocellular damage and v
accine development in large population of the HCV-infected patients. (C) 20
01 European Association for the Study of the Liver. Published by Elsevier S
cience B.V. All rights reserved.